Korea FilingsFull brief — $39

DongKoo Bio & Pharma Co., Ltd.

(주)동구바이오제약 · KOSDAQ: 006620 · Pharmaceuticals and medicinal chemicals

Key facts

Korean name
(주)동구바이오제약
Market / ticker
KOSDAQ · 006620
Industry
Pharmaceuticals and medicinal chemicals
Established
1983-07-01
Fiscal year ends
December
Website
www.dongkoo.com
DART corp code
00114686
Latest revenue
₩242.7B (FY2025)

Items worth checking

No rule-based items found in the latest annual report or the last 12 months of filings. This is a limited automated check, not a clean bill of health.

Financial summary

KRWFY2023FY2024FY2025
Revenue₩215.7B₩249.3B₩242.7B
Operating income₩14.6B₩12.7B₩9.2B
Net income₩11.8B₩2.0B₩50.2B
Total assets₩191.1B₩244.1B₩336.3B
Total liabilities₩80.7B₩138.6B₩184.2B
Total equity₩110.4B₩105.4B₩152.2B
Share capital₩14.2B₩14.2B₩14.2B

Consolidated statements · FY2025 operating margin 3.8% · liabilities to equity 121% · Annual report FY2025 (Korean original)

Auditor opinions

PeriodAuditorOpinion
Term 41 (two years prior)한영회계법인Unqualified
Term 42 (prior)한영회계법인Unqualified
Term 43 (current)삼정회계법인Unqualified

Largest shareholder history

No change history reported in the latest annual report.

Recent filings

DateFilingOriginal
2026-09-15Large shareholding (5%+) reportDART
2026-09-10Amended: Material event reportDART
2026-09-02Large shareholding (5%+) reportDART
2026-08-18Amended: Material event reportDART
2026-08-18Amended: Material event reportDART
2026-08-12Half-year report (2026.06)DART
2026-08-04Large shareholding (5%+) reportDART
2026-07-27Large shareholding (5%+) reportDART
2026-07-22Material event report — Treasury share acquisition trust contractDART
2026-07-15Large shareholding (5%+) reportDART
2026-07-07Large shareholding (5%+) reportDART
2026-06-29Large shareholding (5%+) reportDART
2026-06-25Amended: Annual report (2025.12)DART
2026-06-11Large shareholding (5%+) reportDART
2026-06-05Large shareholding (5%+) reportDART
2026-05-26Large shareholding (5%+) reportDART
2026-05-15Quarterly report (2026.03)DART
2026-05-13Large shareholding (5%+) reportDART
2026-04-02Large shareholding (5%+) reportDART
2026-04-01Independent director appointment / dismissal / resignationDART

Showing the 20 most recent of 37 filings. The full brief lists all of them.

Full brief on DongKoo Bio & Pharma Co., Ltd. — $39 Get the full brief

For business customers. EU companies: enter your VAT number at checkout and no VAT is charged (reverse charge).

Other Korean companies in Pharmaceuticals and medicinal chemicals

Data generated 2026-09-16 from OpenDART.

This page summarizes public filings from DART, the official electronic disclosure system of Korea. It is not investment, credit or legal advice. Figures are shown in the currency the company reports in. Titles and labels are machine-translated and may contain errors — always check the linked original filing. Source: OpenDART, Financial Supervisory Service, Korea.